P3 Health Partners Inc.
Company Stats
- Market Cap
- $22.7M
- as of Sep 30, 2026
- Enterprise Value
- $271.1M
- Shares Outstanding
- 7.3M
- Free Float
- 74.0%
Income Statement
- Revenue
- $1.5B
- Operating Income
- -$270.3M
- Net Income
- -$147.9M
- EBITDA
- -$268.1M
- Revenue Growth, 3Y
- 11.6%
Balance Sheet
- Cash & Equivalents
- $25.0M
- Total Debt
- $273.4M
- Net Debt
- $248.4M
Returns & Capital
- SBC, 3Y Avg
- $5.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.5B | — | — |
| FY2024 | $1.5B | -$110.1M | -7.3% |
| FY2023 | $1.3B | -$77.9M | -6.1% |
| FY2022 | $1.0B | -$128.3M | -12.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges